Jounce Therapeutics Overview
Jounce Therapeutics Discounted Cash Flow
DCF Analysis for JNCE.
Get informed when a big investor buys or sells
+ FollowFair Value
$3.79
Current Fair Value
$3.79
↑ 101.8% Upside
Undervalued by 101.8% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison